Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Akkaraju Srinivas
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   3,961,226    

Indirect Shares

   37,470,445      
Direct Value   $19,777,359    

Indirect Value

   $284,237,840      
Total Shares   41,431,671      
Total Value   $304,015,198      


Seagen Inc $9,493,396 Paratek Pharmaceuticals Inc $2,635,786 Icagen Inc $0 MEI Pharma Inc $7,633,464 Aravive Inc $1,276 Syros Pharmaceuticals, Inc. $13,437 Seagen Inc $9,493,396 Paratek Pharmaceuticals Inc $2,635,786 Icagen Inc $0 MEI Pharma Inc $7,633,464 Aravive Inc $1,276 Syros Pharmaceuticals, Inc. $13,437
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    3    

     Stock price went up :
    4   
    1    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   4.0   
   4.0   
     Percentage Gain/Loss :
   27.3%
 -84.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmos Corp PARS Director 0 2006-10-25 2,845,160    Premium*  
            Seagen Inc SGEN Director 2020-05-15 41,503 2008-09-22 600,559    Premium*  
            Paratek Pharmaceuticals Inc PRTK Former 10% Beneficial ... 2011-07-19 1,181,967 0    Premium*  
            World Heart Corp WHRT 10% Owner 2012-08-02 0 2010-01-26 0    Premium*  
            Icagen Inc ICGN 2011-07-28 200,500 0    Premium*  
            Synageva BioPharma Corp GEVA Former Director 0 2012-06-27 1,026,832    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2012-07-24 0 2012-07-24 3,028,439    Premium*  
            MEI Pharma Inc MEIP 10% Owner 2013-02-19 2,502,775 0    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 609,455    Premium*  
            aTyr Pharma Inc LIFE Former 10% Owner, Dire... 2015-05-12 0 2015-05-12 1,866,126    Premium*  
            Aravive Inc ARAV Director 2019-12-02 31,815 2019-12-02 576,066    Premium*  
            Syros Pharmaceuticals, Inc. SYRS Director 2023-12-21 2,666 2023-12-21 1,786,427    Premium*  
            Principia Biopharma Inc PRNB Director 2018-09-18 0 2018-09-18 383,480    Premium*  
            Chinook Therapeutics Inc KDNY Director 2023-08-11 0 2023-08-11 0    Premium*  
            Graphite Bio, Inc. GRPH 10% Owner 2021-06-29 0 2022-04-12 8,497,067    Premium*  
            Scholar Rock Holding Corp SRRK Director, 10% Owner 0 2023-10-16 6,788,609    Premium*  
            Cargo Therapeutics, Inc. CRGX 10% Owner 0 2023-11-14 4,121,689    Premium*  
            Mineralys Therapeutics, Inc. MLYS 2024-02-12 0 2024-02-12 5,074,916    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-02-27 0 2024-02-27 265,620    Premium*  
* Premium Members only  

Records found :    123         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ARAV Aravive Inc Director   –       •      –    2015-06-29 4 A $0.00 $0 D/D 4,575 4,575 0 -
ARAV Aravive Inc Director   –       •      –    2016-06-14 4 A $0.00 $0 D/D 6,900 11,475 0 -
ARAV Aravive Inc Director   –       •      –    2016-10-03 4 B $12.25 $7,000,005 I/I 571,429 571,429 2.1 -
ARAV Aravive Inc Director   –       •      –    2017-03-24 4 B $12.25 $7,000,005 I/I 571,429 571,429 2.1 -
ARAV Aravive Inc Director   –       •      –    2017-05-25 4 A $0.00 $0 D/D 3,480 14,955 0 -
ARAV Aravive Inc Director   –       •      –    2017-12-01 4 B $2.13 $893,961 I/I 419,700 991,129 2.1 -
ARAV Aravive Inc Director   –       •      –    2017-12-04 4 B $2.21 $1,135,657 I/I 513,872 1,505,001 2.1 -
ARAV Aravive Inc Director   –       •      –    2017-12-05 4 B $2.00 $85,790 I/I 42,895 1,547,896 2.1 -
ARAV Aravive Inc Director   –       •      –    2017-12-20 4 A $0.00 $0 D/D 11,200 26,155 0 -
ARAV Aravive Inc Director   –       •      –    2018-06-06 4 B $1.74 $1,149,585 I/I 660,681 2,234,732 2.1 -
ARAV Aravive Inc Director   –       •      –    2018-06-07 4 B $1.85 $301,964 I/I 163,224 2,397,956 2.1 -
ARAV Aravive Inc Director   –       •      –    2018-06-08 4 B $2.00 $463,160 I/I 231,580 2,629,536 2.1 -
ARAV Aravive Inc Director   –       •      –    2018-06-13 4 B $2.13 $112,928 I/I 53,018 2,682,554 2.1 -
ARAV Aravive Inc Director   –       •      –    2018-10-12 4 A $0.00 $0 D/D 27,456 31,815 0 -
ARAV Aravive Inc Director   –       •      –    2019-12-02 4 B $7.50 $999,998 I/I 133,333 576,066 2.1 -
LIFE aTyr Pharma Inc Former 10% Owner   –       •      –    2015-05-12 4 B $14.00 $4,480,000 I/I 320,000 1,866,126 2.1 -
LIFE aTyr Pharma Inc Former 10% Owner   –       •      –    2015-05-12 4 A $0.00 $0 I/I 1,546,126 1,546,126 0 -
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-09 3 IO $0.00 $0 I/I 0 73,700 -
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-14 4 B $15.00 $9,999,990 I/I 666,666 4,121,689 1.5 -
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-14 4 A $0.00 $0 I/I 3,381,323 3,455,023 0 -
KDNY Chinook Therapeutics Inc Director   –       •      –    2020-10-05 4 A $0.00 $0 I/I 3,168,388 3,168,388 0 -
KDNY Chinook Therapeutics Inc Director   –       •      –    2021-08-18 4 B $11.98 $2,497,830 I/I 208,500 3,376,888 2.1 %
KDNY Chinook Therapeutics Inc Director   –       •      –    2021-11-15 4 B $14.00 $17,010,000 I/I 1,215,000 4,591,888 2.1 %
KDNY Chinook Therapeutics Inc Director   –       •      –    2022-05-27 4 B $14.00 $7,980,000 I/I 570,000 5,161,888 2.1 %
KDNY Chinook Therapeutics Inc Director   –       •      –    2023-05-26 4 OE $0.00 $0 D/D 3,300 3,300 0 -
  123  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us